Search results
Results from the WOW.Com Content Network
The Travel Document for Return to Japan (Japanese: 帰国のための渡航書) is a travel document valid for one-way travel issued by a Japanese diplomatic mission abroad to a Japanese national residing or staying in an area outside Japan whose Japanese passport has been stolen, lost, damaged, expired, or is no longer in their possession, and who must urgently return to Japan. [1]
The COVID-19 vaccination in Japan began on 17 February 2021, more than a month after the first anniversary of the beginning of the pandemic in the country was commemorated. As of 22 October 2021, about 96.4 million people in Japan received at least one dose of the COVID-19 vaccine, while about 86.9 million were fully vaccinated.
The re-entry permit in Japan also exists in the form of a stamp, known as 再入国許可 (Japan Re-entry Permit), which is affixed to a foreign passport or other travel document and serves as a re-entry visa. Foreign nationals planning to travel outside Japan for more than one year are required to obtain a re-entry permit.
On 28 January 2021, the European Union has reinstated a travel ban from Japan due to an alarming rise in COVID-19 cases. Hence, Japan is no longer a part of the EU's safe countries list. [101] The following countries are listed as safe countries amidst the pandemic – Australia, Rwanda, Singapore, South Korea, New Zealand and Thailand.
Main page; Contents; Current events; Random article; About Wikipedia; Contact us; Help; Learn to edit; Community portal; Recent changes; Upload file
Scanning electron micrograph of SARS virions. Severe acute respiratory syndrome (SARS) is the disease caused by SARS-CoV-1. It causes an often severe illness and is marked initially by systemic symptoms of muscle pain, headache, and fever, followed in 2–14 days by the onset of respiratory symptoms, [13] mainly cough, dyspnea, and pneumonia.
Yoshihide Suga, the prime minister of Japan vaccinated with a COVID-19 vaccine. COVID-19 vaccination in Japan started later than in most other major economies. [4] The country has frequently been regarded as "slow" in its vaccination efforts. [5] [6] Japan has so far approved Pfizer–BioNTech, Moderna and Oxford–AstraZeneca for use.
The 2024 Travel and Tourism Competitiveness Report ranked Japan 3rd out of 141 countries overall, which was the highest in Asia. Japan gained relatively high scores in almost all of the featured aspects, such as health and hygiene, safety and security, cultural resources and business travel.